0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Longitudinal Assessment of Small Fiber Neuropathy Evidence of a Non–Length-Dependent Distal Axonopathy

Mohammad A. Khoshnoodi, MD1; Shaun Truelove, BA2; Ahmet Burakgazi, MD3; Ahmet Hoke, MD, PhD1; Andrew L. Mammen, MD, PhD1,4; Michael Polydefkis, MD, MHS1
[+] Author Affiliations
1Department of Neurology, Johns Hopkins University, Baltimore, Maryland
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
3Neuroscience Section, Department of Medicine, Virginia Tech Carilion School of Medicine, Roanoke
4Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland
JAMA Neurol. 2016;73(6):684-690. doi:10.1001/jamaneurol.2016.0057.
Text Size: A A A
Published online

Importance  Few data are available on the natural history of small fiber neuropathy (SNF). Peripheral neuropathy typically follows a length-dependent pattern, leading us to hypothesize that patients with SFN would lose intraepidermal nerve fibers at the distal leg more quickly than at more proximal thigh sites.

Objective  To compare the longitudinal rate and pattern of intraepidermal nerve fiber density (IENFD) change in idiopathic SFN (iSFN), impaired glucose tolerance–associated SFN (IGT-SFN), and diabetes mellitus–associated SFN (DM-SFN).

Design, Setting, and Participants  In this longitudinal, case-control study, patients diagnosed as having SFN from January 1, 2002, through December 31, 2010, and age- and sex-matched controls underwent additional evaluation at tertiary outpatient neurology clinics. Participants and healthy controls were evaluated twice separated by at least 2 years. Participants underwent standardized examinations, nerve conduction, and skin biopsy at 3 sites along the leg. A linear mixed-effects model was used to compare rates of IENFD decrease between cause and biopsy site.

Main Outcomes and Measures  We compared the rate of IENFD loss over time in subjects with iSFN, IGT-SFN and DM-SFN as well as the spatiotemporal pattern of IENF loss at different rostal-caudal sites along the leg.

Results  Fifty-two participants (25 with iSFN, 13 with IGT-SFN, and 14 with DM-SFN) and 10 healthy controls were evaluated. Mean (SD) ages were 50.9 (12.9), 63.1 (10.4), and 61.6 (11.6) years for the iSFN, IGT-SFN, and DM-SFN groups, respectively. There were 12, 7, and 8 female patients and 13, 6, and 6 male patients in the iSFN, IGT-SFN, and DM-SFN groups, respectively. The mean follow-up time was 24.2, 26.7, and 38.8 months for those with iSFN, IGT-SFN, and DM-SFN, respectively, and 32 months for healthy controls. At baseline, mean (SE) for distal leg IENFD (6.48 [1.06]) was lower than distal thigh (13.32 [1.08]) and proximal thigh IENFD (19.98 [1.07]) (P = .001). In addition, IENFD was significantly lower in patients with DM-SFN and IGT-SFN compared with iSFN at all biopsy sites (P = .001). All 3 neuropathy groups had significant IENFD decrease at follow-up at all 3 sites (P = .002), whereas there was no change in the control group. The mean yearly rates of IENFD change over time at the distal leg, distal thigh, and proximal thigh irrespective of cause are −1.42, −1.59, and −2.8 fibers per millimeter, respectively. The mean slopes of IENFD change over time by cause regardless of biopsy site are −0.179, −0.164, and −0.198 for iSFN, IGT-SFN, and DM-SFN, respectively. No difference was found between SFN groups in the rate of decrease. The rate of IENFD decrease was similar at all 3 biopsy sites.

Conclusions and Relevance  Similar rates of IENFD decrease irrespective of cause were observed. Epidermal nerve fibers were lost at similar rates in proximal and distal sites, suggesting that SFN is a non–length-dependent terminal axonopathy.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Figures

Place holder to copy figure label and caption
Figure 1.
Change in Intraepidermal Nerve Fiber Density (IENFD) Over Time

Comparison of mean IENFD at baseline and follow-up across biopsy sites. IENFD was observed to decrease more in the distal leg compared with the proximal thigh and more in patients with diabetes mellitus–associated small fiber neuropathy (DM-SFN) and impaired glucose tolerance–associated small fiber neuropathy (IGT-SFN) than in patients with idiopathic small fiber neuropathy (iSFN). Over time, there was a similar decrease in IENFD in the distal and proximal sites of biopsy with similar rates among patients with DM-SFN, IGT-SFM, and iSFN. Error bars indicate 95% CIs.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Reduction of Intraepidermal Nerve Fiber Density (IENFD) in 3 Sites of Skin Biopsy

A, The rate of reduction in IENFD is calculated by subtracting the density in the follow-up biopsy from the density in the initial biopsy and is grouped per cause and color-coded for biopsy site. B, Rate of IENFD reduction per year. Both measures indicate that the reduction in fiber density happens in the proximal and distal sites with similar rates regardless of the cause. Error bars indicate ± 2 SDs. DM-SFN indicates diabetes mellitus–associated small fiber neuropathy; IGT-SFN, impaired glucose tolerance–associated small fiber neuropathy; and iSFN, idiopathic small fiber neuropathy.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.
Length-Dependent Pattern of Axon Loss vs Non–Length-Dependent Distal Axonopathy

Left, Length-dependent pattern of axon loss where the most caudal projection of the longer axons are preferentially lost while more proximal sites remain constant. Right, Pattern observed in the study participants where distal projections of axons were lost at equal rates irrespective of rostral and caudal location along the leg. Gray fibers represent nerve fiber branches that have degenerated, whereas black nerve fibers are healthy. The flow of sand through the hourglasses depicts the rate of epidermal nerve fiber loss at each site. Blue dots indicate the locations of biopsy sites.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,598 Views
1 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Diabetic Peripheral Neuropathy

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Make the Diagnosis: Diabetic Peripheral Neuropathy

brightcove.createExperiences();